Please login to the form below
Arrow
This page shows the latest Arrow news and features for those working in and with pharma, biotech and healthcare.
RET rivals Loxo and Blueprint face off with early-stage data
The ARROW trial revealed that 90% of patients with RET-altered medullary and papillary thyroid cancers had reduction in tumour volume overall, with a 62% response rate in medullary patients treated
Latest news
-
Lundbeck challenge to EC pay-for-delay ruling fails
The four generics companies - Generics UK, Arrow, Alpharma and Ranbaxy - were fined around 52m, and those judgments have also been upheld by the General Court of the EU.
-
Novartis enters PD-1 race via CoStim acquisition
Immunotherapy agents provide additional arrows in our quiver for such combinations.
-
EC fines pharma companies €146m for generic Celexa delay
Lundbeck, Alpharma, Merck KGaA, Generics UK, Arrow and Ranbaxy all hit. ... UK (part of Mylan), Actavis unit Arrow and Ranbaxy.
-
Nine pharma firms face EU fines over pay-for-delay deals
Lundbeck, Merck KGaA, Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma and Ranbaxy are all in line for financial penalties from the European Commission (EC), according to Reuters.
-
Communicating clearly: using PowerPoint properly
Use phrases, not sentences. Add arrows or boxes to highlight key points, eg difference on Kaplan-Meier curves.
Lundbeck challenge to EC pay-for-delay ruling fails
Novartis enters PD-1 race via CoStim acquisition
EC fines pharma companies €146m for generic Celexa delay
Communicating clearly: using PowerPoint properly
More from news
Approximately 1 fully matching, plus 19 partially matching documents found.
Latest Intelligence
-
The doctor will see you now?
As said initially, long waiting is not a matter of money, number of staff or size of arrows between squares in an organisation's chart.
-
Healthcare industry apps
Dr Trombino. Dr Trombino's arrows contain a direct thrombin inhibitor: fire them at the yellow factors to prevent the formation of blood clots!
The doctor will see you now?
Healthcare industry apps
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Dr David Chiswell joins Kymab
He brings over 30 years of biotechnology expertise to the firm, having held senior management positions at a number of pharmaceutical companies, including Arakis, Arrow Therapeutics, Daniolabs and Sosei.
Dr David Chiswell joins Kymab
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
A MacCulloch Associates 'AMA' Ltd
Address:. 3 Arrow Court. Adams Way , Springfield Business Park. Alcester.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US demand for COVID-19 antibody treatments rising fast
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
- AstraZeneca invests in RNA tech platform
- Market shaping demands behaviour change
- Healthcare Access and Payment Reform in the US
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- $47.5m research centre to seek genetic insights into disease
- New data from Moderna supports COVID boosters
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
